NPI: 1134516206 · CORONA, CA 92882 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/16/2015
Authorized official WINSTEL, JOHN controls 20+ related entities in our dataset. Read more
| Authorized Official | WINSTEL, JOHN (CIEF ACCOUNTING OFFICER) |
| NPI Enumeration Date | 04/16/2015 |
Other providers sharing the same authorized official: WINSTEL, JOHN
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 606 | $64K |
| 2019 | 9,876 | $341K |
| 2020 | 13,765 | $453K |
| 2021 | 16,381 | $528K |
| 2022 | 15,041 | $509K |
| 2023 | 15,654 | $701K |
| 2024 | 9,912 | $839K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 27,073 | 2,469 | $3.35M |
| A4657 | Syringe, with or without needle, each | 3,803 | 1,277 | $37K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 24,000 | 1,705 | $16K |
| J1756 | Injection, iron sucrose, 1 mg | 7,742 | 1,846 | $14K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 568 | 334 | $11K |
| J1270 | Injection, doxercalciferol, 1 mcg | 10,124 | 906 | $3K |
| 82728 | 351 | 327 | $688.80 | |
| 83970 | 879 | 851 | $289.21 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 63 | 62 | $67.29 |
| 90674 | 60 | 57 | $66.28 | |
| 83550 | 283 | 261 | $37.08 | |
| 83540 | 325 | 302 | $29.32 | |
| 85041 | 974 | 897 | $26.68 | |
| 85048 | 885 | 823 | $22.79 | |
| 85045 | 120 | 108 | $0.00 | |
| 82108 | 27 | 27 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 156 | 127 | $0.00 |
| 0250 | 3,789 | 235 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 13 | 13 | $0.00 |